[Recommendations] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control Addendum (May 30, 2024)
date : 5/30/2024
Tags: Cardiovascular Diseases, NCDs
![[Recommendations] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control Addendum (May 30, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/ncd-cvd-20240530-top_ENG.png)
The Health and Global Policy Institute (HGPI) Cardiovascular Disease Control Promotion Project formulated policy recommendations titled, “Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control Addendum.”
For details, please view the PDF provided bottom.
■ Background to the creation of this addendum and its objectives
In Japan, cardiovascular diseases (CVDs) like stroke and heart disease are leading causes of death and the most common conditions that require long-term care. To advance all varieties of CVD control measures, Japan enacted the “Basic Act on Countermeasures for Stroke, Heart Disease and Other CVDs to Extend Healthy Life Expectancies” (or the “Basic Act on CVD Measures”) in December 2018. Later, the Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease was formulated in accordance with that Act and approved by Cabinet Decision in October 2020. Under the National Plan, each prefectural government formulated a Prefectural Plan for the Promotion of CVD Countermeasures (referred to as “Prefectural Plans” below) and is now advancing efforts to promote CVD control. While Japan has laid the groundwork to further advance CVD control measures, the Basic Act and the Basic Plan only outline general principles and goals. Expectations are now growing for the national Government and prefectural governments to make concrete progress on these measures and expand them in the future. Given this context, in the latter half of 2021, Health and Global Policy Institute (HGPI) launched the three-year Cardiovascular Disease Control Promotion Project to provide strong backing to the formulation of Prefectural Plans. Looking back on the first two years of this project, in its first year, we set a direction and compiled perspectives for considering CVD control in policy recommendations, and in its second year, we gathered knowledge and identified methodologies for implementing CVD control in prefectures in accordance with those perspectives. In response to the Second Phase of the Basic Plan, which came into effect after a revision in April 2023, in the second year of our activities, this project worked to identify issues that must be addressed for the formulation of phase two Prefectural Plans, with our main focus on measures at prefectural governments. As of the time of writing, in April 2024, all prefectures are now in the final stages of reviewing their respective plans. At this stage, they will clarify the roles of each stakeholder and proceed with the actual introduction of countermeasures. Given these circumstances, to drive concrete progress in CVD control, activities for year three of the HGPI CVD Control Promotion Project have included sharing approaches, perspectives, and implementation strategies and methodologies we have accumulated thus far through opinion exchanges with prefectural officials and council members. In the course of those discussions, government officials and collaborators from academia provided us with new knowledge that was not fully captured in the recommendations presented in our project’s second year. For this reason, we compiled this addendum describing each stakeholders’ roles in the future implementation of CVD control measures. It is our sincere hope that these recommendations can once again be shared with and utilized by all related parties to contribute to steady future progress in CVD control.
Top Research & Recommendations Posts
- [Policy Recommendation] Preparing for “Disaster-Level Heat” in the 2025 Basic Policy on Economic and Fiscal Management and Reform (June 9, 2025)
- [Policy Recommendation] Integrating “Planetary Health” as a Growth Strategy — Proposal for the Grand Design and Action Plan for a New Form of Capitalism (2025 Revised Edition) (June 9, 2025)
- [Event Report] Round Table Discussion “Understanding Menopausal Women’s Health as a Social Issue” (November 19, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] HGPI Joint Input to the Zero Draft Political Declaration on NCDs and Mental Health (May 23, 2025)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
Featured Posts
-
2025-07-04
[Registration Open] (Webinar) The 136th HGPI Seminar “Where We Are Now and Where We Are Going Regarding PPI in Mental Health Research: Learning from the TOGETHER Project in the Form of Co-Creation” (July 28, 2025)
-
2025-07-04
[Event Report] The HGPI Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-07-04
[HGPI Policy Column] (No. 62) From the Dementia Project “The Current State of Dementia Policy in the International Community in 2025”
-
2025-07-04
[Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)